Barbara Hendrickson to Humans
This is a "connection" page, showing publications Barbara Hendrickson has written about Humans.
Connection Strength
0.080
-
How Aggregate Safety Assessment Planning Supports Investigational New Drug Safety Reporting Decisions. Ther Innov Regul Sci. 2024 Jul; 58(4):579-590.
Score: 0.030
-
Aggregate IND Safety Reporting for Smaller Companies and Programs. Ther Innov Regul Sci. 2024 03; 58(2):368-379.
Score: 0.007
-
Gastric inflammation as a feature of ulcerative colitis. J Pediatr Gastroenterol Nutr. 2003 Sep; 37(3):228-9.
Score: 0.007
-
MMR vaccination, ileal lymphoid nodular hyperplasia, and pervasive develop-mental disorder. Lancet. 2002 Jun 15; 359(9323):2051-2.
Score: 0.007
-
Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002 Jan; 15(1):79-94.
Score: 0.006
-
Interdisciplinary Safety Evaluation for Learning and Decision-Making. Ther Innov Regul Sci. 2021 07; 55(4):705-716.
Score: 0.006
-
Global Regulatory Landscape for Aggregate Safety Assessments: Recent Developments and Future Directions. Ther Innov Regul Sci. 2020 03; 54(2):447-461.
Score: 0.006
-
A Framework for Safety Evaluation Throughout the Product Development Life-Cycle. Ther Innov Regul Sci. 2020 07; 54(4):821-830.
Score: 0.006
-
Local vaccine site reactions and contact allergy to aluminum. Pediatr Dermatol. 2012 Jan-Feb; 29(1):68-72.
Score: 0.003
-
Protective role of HSP72 against Clostridium difficile toxin A-induced intestinal epithelial cell dysfunction. Am J Physiol Cell Physiol. 2003 Apr; 284(4):C1073-82.
Score: 0.002